Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Illumina's (ILMN) Grail Merger in Trouble as FTC Files Suit
09:51am, Wednesday, 31'st Mar 2021
According to FTC, the Illumina (ILMN) and Grail merger will diminish the scope of innovation in the U.S. market for MCED tests.
Despite FTC Challenges Opposing Grail Acquisition, Illumina Committed To Pursue Deal: Report
06:12am, Wednesday, 31'st Mar 2021
The Federal Trade Commission (FTC) is reportedly looking to stop Illumina Inc's (NASDAQ: ILMN) $7.1 billion proposed acquisition of Grail Inc. FTC believes that the deal would slow innovation in canc
The FTC Wants to Block Illumina's Deal For Grail
09:12pm, Tuesday, 30'th Mar 2021
Blood-tests that screen for many kinds of cancer would revolutionize healthcare. Most are being developed for use with Illumina's gene sequencers, so the FTC fears that Illumina's deal to acquire test
Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
03:17pm, Tuesday, 30'th Mar 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina commits to pursuing GRAIL acquisition to accelerate access to breakthrough multi-cancer early detection blood test.
Ark Funds, Illumina Invest In SomaLogic SPAC Deal: What Investors Should Know
11:16am, Monday, 29'th Mar 2021
A leader in the proteomics field is going public with a SPAC deal announced Monday. The SPAC Deal: SomaLogic announced a SPAC deal with CM Life Sciences II Inc (NASDAQ: CMIIU), valuing the company at
2,500% Returns? This Stock Is Like Buying Illumina in 2007
10:01am, Monday, 29'th Mar 2021
10x Genomics is powering the next generation of biotech research.
3 Top Stocks to Buy to Profit From the Healthcare Revolution
06:04am, Sunday, 28'th Mar 2021
From genomics to virtual care, these stocks should be huge long-term winners.
Final Trades: Illumina, Rackspace, Jumia & more
01:45pm, Friday, 19'th Mar 2021
The "Halftime Report" traders give their top picks to watch for the second half.
Why You Should Hold on to Illumina (ILMN) Stock for Now
10:59am, Thursday, 18'th Mar 2021
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and robust adoption of products.
Iridia Raises $24 Million in Series B Funding
07:30am, Tuesday, 16'th Mar 2021
Oversubscribed Financing to Build World's First High-Density DNA-Based Memory Chip Oversubscribed Financing to Build World's First High-Density DNA-Based Memory Chip
Top 5 Holdings of Investment Firm Baillie Gifford
05:00pm, Friday, 12'th Mar 2021
We are pleased to announce that we added Scotland-based investment firm Baillie Gifford (Trades, Portfolio) to our Premium list of gurus. According to top 10 holdings statistics, the firm's top five h
7 Healthcare Stocks to Buy and Hold for the Long Term
11:43am, Friday, 12'th Mar 2021
These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared firs
Why You Should Own Biotech Stocks Now
03:00pm, Thursday, 11'th Mar 2021
The confluence of healthcare and technology will send many biotech stocks soaring over the next decade.
Illumina (ILMN) NGS-Based Platform Approved for Use in Russia
10:37am, Monday, 08'th Mar 2021
Illumina and R-Pharm's in-vitro diagnostics platform registration will drive the expansion of Next Generation Sequencing-based clinical diagnostics across Russia.
Illumina: Gene Sequencing Leader In The Golden Age Of Genetics
06:04am, Monday, 08'th Mar 2021
Illumina is strategically positioning itself as a key player in high growth segments of the genomic revolution. Illumina's metrics show that it is another perennially high priced stock.
